• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人癌症患者中艰难梭菌感染的风险。

Risk for Clostridiodes difficile Infection among Older Adults with Cancer.

出版信息

Emerg Infect Dis. 2019 Sep;25(9):1683-9. doi: 10.3201/eid2509.181142.

DOI:10.3201/eid2509.181142
PMID:31442017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6711221/
Abstract

To assess whether risk for Clostridiodes difficile infection (CDI) is higher among older adults with cancer, we conducted a retrospective cohort study with a nested case-control analysis using population-based Surveillance, Epidemiology, and End Results-Medicare linked data for 2011. Among 93,566 Medicare beneficiaries, incident CDI and odds for acquiring CDI were higher among patients with than without cancer. Specifically, risk was significantly higher for those who had liquid tumors and higher for those who had recently diagnosed solid tumors and distant metastasis. These findings were independent of prior healthcare-associated exposure. This population-based assessment can be used to identify targets for prevention of CDI.

摘要

为了评估癌症老年患者发生艰难梭菌感染(CDI)的风险是否更高,我们利用基于人群的监测、流行病学和最终结果-医疗保险链接数据进行了一项回顾性队列研究,并进行了嵌套病例对照分析,该研究的数据时间为 2011 年。在 93566 名医疗保险受益人中,患有 CDI 的患者和发生 CDI 的几率均高于未患有癌症的患者。具体而言,患有液体肿瘤的患者风险显著更高,而最近被诊断出患有实体肿瘤和远处转移的患者风险更高。这些发现与之前的医疗保健相关暴露无关。这种基于人群的评估可用于确定 CDI 预防的目标。

相似文献

1
Risk for Clostridiodes difficile Infection among Older Adults with Cancer.老年人癌症患者中艰难梭菌感染的风险。
Emerg Infect Dis. 2019 Sep;25(9):1683-9. doi: 10.3201/eid2509.181142.
2
Epidemiology of Clostridium difficile infection in hospitalized oncology patients.住院肿瘤患者艰难梭菌感染的流行病学
Am J Infect Control. 2016 Nov 1;44(11):1408-1410. doi: 10.1016/j.ajic.2016.04.210. Epub 2016 Jun 7.
3
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.美国老年人艰难梭菌感染的死亡率和成本
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1331-1336. doi: 10.1017/ice.2016.188. Epub 2016 Aug 30.
4
Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Infection: A Nationwide Analysis.癌症合并感染患者住院发病率和结局的变化趋势:一项全国性分析。
J Natl Compr Canc Netw. 2017 Apr;15(4):466-472. doi: 10.6004/jnccn.2017.0046.
5
Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.艰难梭菌感染相关因素:一项为期三年的前瞻性队列中的巢式病例对照研究。
Anaerobe. 2017 Apr;44:117-123. doi: 10.1016/j.anaerobe.2017.03.003. Epub 2017 Mar 6.
6
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.艰难梭菌感染的负担:来自美国行政数据库的艰难梭菌感染发病率估计
BMC Infect Dis. 2016 Apr 22;16:177. doi: 10.1186/s12879-016-1501-7.
7
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.通过人群归因风险分析确定美国艰难梭菌感染风险最高的医疗保险受益人群。
PLoS One. 2016 Feb 9;11(2):e0146822. doi: 10.1371/journal.pone.0146822. eCollection 2016.
8
Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.养老院患者中艰难梭菌相关疾病的负担:一项基于人群的队列研究。
BMC Geriatr. 2016 Nov 25;16(1):193. doi: 10.1186/s12877-016-0367-2.
9
Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.苏格兰泰赛德地区老年人社区获得性艰难梭菌感染与抗生素暴露及养老院居住有关:嵌套病例对照队列研究
J Antimicrob Chemother. 2013 Dec;68(12):2927-33. doi: 10.1093/jac/dkt257. Epub 2013 Jul 3.
10
Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: A retrospective, case-control study in a tertiary care hospital in Japan.社区获得性艰难梭菌感染的临床特征及危险因素:日本一家三级医院的回顾性病例对照研究
J Infect Chemother. 2015 Dec;21(12):864-7. doi: 10.1016/j.jiac.2015.09.004. Epub 2015 Oct 23.

引用本文的文献

1
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.美国艰难梭菌感染的危险因素及发生时间的系统文献综述
Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.
2
Genomic surveillance of transmission and virulence in a healthcare setting.医疗机构中传播与毒力的基因组监测。
mBio. 2024 Mar 13;15(3):e0330023. doi: 10.1128/mbio.03300-23. Epub 2024 Feb 8.
3
Characteristics, Risk Factors, and Prevalence of Among Hospitalized Patients in a Tertiary Care Hospital in Palestine.

本文引用的文献

1
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.与检测差异相关的艰难梭菌感染率的人为差异。
Emerg Infect Dis. 2018 Mar;24(3):584-587. doi: 10.3201/eid2403.170961.
2
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.美国原发性和复发性艰难梭菌感染患者的医疗资源利用和成本归因分析。
Clin Infect Dis. 2018 Apr 17;66(9):1326-1332. doi: 10.1093/cid/cix1021.
3
Deaths: Final Data for 2015.死亡:2015年最终数据。
巴勒斯坦一家三级医疗医院住院患者的特征、风险因素及患病率。 (你提供的原文最后少了具体病症等关键信息,我按照完整的常见表述翻译了)
Infect Drug Resist. 2021 Nov 9;14:4681-4688. doi: 10.2147/IDR.S333985. eCollection 2021.
4
Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery.围手术期酸碱平衡紊乱对心脏手术患者艰难梭菌感染风险的预后作用。
PLoS One. 2021 Mar 17;16(3):e0248512. doi: 10.1371/journal.pone.0248512. eCollection 2021.
Natl Vital Stat Rep. 2017 Nov;66(6):1-75.
4
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections.基于微生物组的疗法治疗艰难梭菌和抗生素耐药性肠道感染。
Annu Rev Microbiol. 2017 Sep 8;71:157-178. doi: 10.1146/annurev-micro-090816-093549. Epub 2017 Jun 15.
5
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.贝洛妥珠单抗预防复发性艰难梭菌感染。
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
6
Clostridium difficile-Associated Diarrhea in the Oncology Patient.肿瘤患者艰难梭菌相关性腹泻
J Oncol Pract. 2017 Jan;13(1):25-30. doi: 10.1200/JOP.2016.018614.
7
New and emerging therapies for Clostridium difficile infection.艰难梭菌感染的新型及新兴疗法
Curr Opin Infect Dis. 2016 Dec;29(6):546-554. doi: 10.1097/QCO.0000000000000320.
8
Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.住院入院时预测医院获得性艰难梭菌感染(HO-CDI)的风险:HO-CDI风险评分
Infect Control Hosp Epidemiol. 2015 Jun;36(6):695-701. doi: 10.1017/ice.2015.37. Epub 2015 Mar 10.
9
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
10
Multistate point-prevalence survey of health care-associated infections.多州医疗机构相关性感染的时点患病率调查。
N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.